0001179110-21-008366.txt : 20210824 0001179110-21-008366.hdr.sgml : 20210824 20210824135751 ACCESSION NUMBER: 0001179110-21-008366 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210820 FILED AS OF DATE: 20210824 DATE AS OF CHANGE: 20210824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOTT DARCY G CENTRAL INDEX KEY: 0001179972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36568 FILM NUMBER: 211201055 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHEQUITY, INC. CENTRAL INDEX KEY: 0001428336 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 801-727-1000 MAIL ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHEQUITY INC DATE OF NAME CHANGE: 20080227 4 1 edgar.xml FORM 4 - X0306 4 2021-08-20 1 0001428336 HEALTHEQUITY, INC. HQY 0001179972 MOTT DARCY G C/O HEALTHEQUITY, INC. 15 W. SCENIC POINTE DR., STE. 100 DRAPER UT 84020 0 0 0 1 Special Advisor Common Stock 2021-08-20 4 M 0 10000 14.00 A 93052 D Common Stock 2021-08-20 4 S 0 5631 62.6908 D 87421 D Common Stock 2021-08-20 4 S 0 369 63.3292 D 87052 D Stock Option (right to buy) 14 2021-08-20 4 M 0 10000 0 D 2024-07-30 Common Stock 10000 30000 D Stock Option (right to buy) 25.39 2025-03-26 Common Stock 25000 25000 D Stock Option (right to buy) 41.28 2027-03-27 Common Stock 19897 19897 D Stock Option (right to buy) 61.72 2028-03-27 Common Stock 14228 14228 D Stock Option (right to buy) 73.61 2029-03-26 Common Stock 15337 15337 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.21 to $63.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) and (3) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.32 to $63.34, inclusive. The option is immediately exercisable. The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022. The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023. /s/ Darcy G. Mott 2021-08-24